Spectral AI Schedules 2023 Third Quarter Financial Results and Conference CallGlobeNewsWire • 11/01/23
Spectral AI names Prof. Paul Chadwick, Former CEO of the Royal College of Podiatry UK, as Senior Executive for UK and EMEAGlobeNewsWire • 10/24/23
Spectral AI shares surge as wound imaging device wins regulatory approvals in US and UKProactive Investors • 10/19/23
Spectral AI's DeepView SnapShot® Wound Imaging System, Achieves UKCA Mark and FDA Class 1 Medical Device ClassificationGlobeNewsWire • 10/19/23
Spectral AI expands diabetic foot ulcer study to additional clinical sitesProactive Investors • 10/16/23
Spectral AI Adds Additional Clinical Sites to Multi-Center Diabetic Foot Ulcer (DFU) StudyGlobeNewsWire • 10/16/23
Spectral AI CEO, Wensheng Fan, to Participate in AI Healthcare Panel at Accelerate Health ConferenceGlobeNewsWire • 10/05/23
Spectral AI Adds Healthcare Services Leader and Population Health Expert Deepak Sadagopan to Board of DirectorsGlobeNewsWire • 10/02/23
Spectral MD Awarded BARDA Project BioShield Contract Valued at $149 Million for AI-Driven DeepView® Burn Wound Imaging TechnologyGlobeNewsWire • 09/28/23
Spectral AI to Present at 2023 Cantor Fitzgerald Global Healthcare ConferenceGlobeNewsWire • 09/20/23